Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.054 EUR
−7.62 M EUR
57.04 M EUR
172.49 M
About SOMNOMED LIMITED
Sector
Industry
Headquarters
Sydney
Website
Founded
1987
ISIN
AU000000SOM1
FIGI
BBG000R00P67
SomnoMed Ltd. engages in the production and sale of devices for the oral treatment of sleep related disorders. Its products include SomnoDent, SomMorning Repositioner, SomnoBrux, SomTabs, and Sunrise Sleep Test. It operates through the following geographical segments: North America, Europe, and Asia Pacific. The company was founded in 2004 and is headquartered in Sydney, Australia.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange SOMNOMED LTD. stocks are traded under the ticker RJV.
We've gathered analysts' opinions on SOMNOMED LTD. future price: according to them, RJV price has a max estimate of 0.26 EUR and a min estimate of 0.26 EUR. Watch RJV chart and read a more detailed SOMNOMED LTD. stock forecast: see what analysts think of SOMNOMED LTD. and suggest that you do with its stocks.
Yes, you can track SOMNOMED LTD. financials in yearly and quarterly reports right on TradingView.
SOMNOMED LTD. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
RJV earnings for the last half-year are 0.00 EUR per share, whereas the estimation was 0.00 EUR, resulting in a −133.33% surprise. The estimated earnings for the next half-year are 0.00 EUR per share. See more details about SOMNOMED LTD. earnings.
SOMNOMED LTD. revenue for the last half-year amounts to 28.94 M EUR, despite the estimated figure of 28.94 M EUR. In the next half-year revenue is expected to reach 29.47 M EUR.
RJV net income for the last half-year is −3.67 M EUR, while the previous report showed −3.91 M EUR of net income which accounts for 6.29% change. Track more SOMNOMED LTD. financial stats to get the full picture.
No, RJV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SOMNOMED LTD. EBITDA is −1.86 M EUR, and current EBITDA margin is −2.77%. See more stats in SOMNOMED LTD. financial statements.
Like other stocks, RJV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SOMNOMED LTD. stock right from TradingView charts — choose your broker and connect to your account.